Drawing for CP CRANBURY PHARMACEUTICALS

USPTO serial 98397270

CP CRANBURY PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 8503734Status 700Registered
Filing date
Status date
Registration date
Oct 13, 2026
Examiner
MORAN, CAROLINE L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CP CRANBURY PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cathy Kodroff

Cathy Kodroff Howson & Howson, LLP325 Sentry Parkway EastFive Sentry East, Suite 160Blue Bell, PA 19422

Goods and services

ClassDescriptionStatusFirst use
005Prescription generic pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, diabetes, high cholesterol, high blood pressure, bacterial infections, malaria, hyperuricemia, gout, central nervous system disorders, namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia, bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief, and for anti-inflammationACTIVEJun 16, 2026
035Distributorship of prescription and non-prescription generic pharmaceutical medicines and preparationsACTIVEJun 16, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 23, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 15, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 25, 2026IUAFUSE AMENDMENT FILED—
Aug 25, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 7, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 6, 2026EX1GSOU EXTENSION 1 GRANTED—
Mar 6, 2026EXT1SOU EXTENSION 1 FILED—
Mar 6, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 15, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 15, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 9, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 10, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jun 10, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 10, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 10, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 28, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 28, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 28, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 28, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 28, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 28, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2024DOCKASSIGNED TO EXAMINER—
Jun 7, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 7, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 8, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance